Findings seen for incidence of overall and 14 site-specific cancers
THURSDAY, Nov. 7, 2024 (HealthDay News) — There is a small inverse association between plasma omega-6 and omega-3 polyunsaturated fatty acids (PUFAs) and cancer, according to a study published online Oct. 17 in the International Journal of Cancer.
Yuchen Zhang, from the University of Georgia in Athens, and colleagues investigated the associations of plasma omega-3 and omega-6 PUFAs with the incidence of cancer (overall and 19 site-specific cancers). The analysis included 253,138 eligible U.K. Biobank participants followed for 12.9 years.
The researchers found that both omega-6 and omega-3 as percentages of total fatty acids were inversely associated with overall cancer incidence (hazard ratios [95 percent confidence intervals] per standard deviation [SD], 0.98 [0.96 to 0.99] and 0.99 [0.97 to 1.00], respectively). Fourteen of the 19 site-specific cancers available were associated with omega-6 percentage and five were associated with omega-3 percentage, all indicating inverse associations, with the exception that prostate cancer was positively associated with omega-3 percentage (hazard ratio per SD, 1.03; 95 percent confidence interval, 1.01 to 1.05).
“Higher omega-3 and omega-6 levels were associated with lower rates of cancer,” Zhang said in a statement. “These findings suggest that the average person should focus on getting more of these fatty acids in their diets.”
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers
Cancer Survivors Have Lower Levels of Physical Activity
Pharmacist-Led Med Review Improves Medication Quality in Older Patients With Cancer
Lower Cognitive Functioning During 60s Linked to Subsequent Stroke Risk
Polypharmacy of Prescription Medications Increased for U.S. Older Adults
Nearly 1 in 10 Older Adults Used Cannabis in the Past Year
Lower Vertebral Bone Mineral Density Linked to Cognitive Decline